Is there a sex difference in mortality rates for deaths occurring in paediatric intensive care units? Systematic literature review protocol by Almossawi, O et al.
1Almossawi O, et al. BMJ Open 2021;11:e046794. doi:10.1136/bmjopen-2020-046794
Open access 
Is there a sex difference in mortality 
rates for deaths occurring in paediatric 
intensive care units? Systematic 
literature review protocol
Ofran Almossawi   ,1 Amanda Friend,2 Luigi Palla,3,4,5 Richard Feltbower,6 
Bianca De Stavola1
To cite: Almossawi O, Friend A, 
Palla L, et al.  Is there a 
sex difference in mortality 
rates for deaths occurring 
in paediatric intensive care 
units? Systematic literature 
review protocol. BMJ Open 
2021;11:e046794. doi:10.1136/
bmjopen-2020-046794
 ► Prepublication history and 
additional material for this paper 
is available online. To view these 
files, please visit the journal 
online (http:// dx. doi. org/ 10. 
1136/ bmjopen- 2020- 046794).
Received 10 November 2020
Revised 07 January 2021
Accepted 21 January 2021
For numbered affiliations see 
end of article.
Correspondence to
Mrs Ofran Almossawi;  
 o. almossawi@ ucl. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction In the general population, female children 
have been reported to have a survival advantage. For 
children admitted to paediatric intensive care units 
(PICUs), mortality has been reported to be lower in males 
despite the higher admission rates for males into intensive 
care. This apparent sex reversal in PICU mortality is not 
well studied. To address this, we propose to conduct a 
systematic literature review to summarise the available 
evidence. Our review will study the reported differences 
in mortality between males and females aged 0–17, who 
died in a PICU, to examine if there is a difference between 
the two sexes in PICU mortality, and if so, to describe the 
magnitude and direction of this difference.
Methods and analysis Studies that directly or indirectly 
addressed the association between sex and mortality 
in children admitted to intensive care will be eligible for 
inclusion. Studies that directly address the association 
will be eligible for data extraction. The search strings 
were based on terms related to the population (children 
in intensive care), the exposure (sex) and the outcome 
(mortality). We used the databases MEDLINE (1946–2020), 
Embase (1980–2020) and Web of Science (1985–2020) as 
these cover relevant clinical publications. We will assess 
the reliability of included studies using the risk of bias in 
observational studies of exposures tool. We will consider a 
pooled effect if we have at least three studies with similar 
periods of follow up and adjustment variables.
Ethics and dissemination Ethical approval is not 
required for this review as it will synthesise data from 
existing studies. This manuscript is a part of a larger data 
linkage study, for which Ethical approval was granted. 
Dissemination will be via peer- reviewed journals and via 
public and patient groups.
PROSPERO registration number CRD42020203009.
BACKGROUND
Child mortality is a global measure of a 
nation’s health and a top priority for the UK 
health system.1 Differences in mortality rates 
between the sexes are well documented in 
almost all developed countries to be in favour 
of higher female over male survival.2 Overall 
childhood mortality is very low in the UK, 
and in other developed countries. Office of 
National Statistics figures over the last two 
decades show downward mortality trends 
for both males and females, and levelling 
off over the last decade. A major contributor 
to the UK number of childhood deaths are 
those associated with an admission to paedi-
atric intensive care unit (PICU), with males 
accounting for around 60% of total admis-
sions.3 PICU deaths account for about 15% 
of all UK childhood fatalities3 and provide a 
sizeable population to study sex differences 
in childhood deaths. This led to the design 
and implementation of a longitudinal study 
of all infants admitted to UK PICUs over 11 
years. The study showed higher mortality for 
female over male infants.4 This difference is 
in the opposite direction to that observed for 
the overall population. This difference could 
be due to variations in severity of disease on 
admission; however, accounting for currently 
available severity scores is not sufficient to 
fully explain the observed sex differences in 
mortality. There is a number of published 
Strengths and limitations of this study
 ► The strengths of our review include systematically 
evaluating all published articles that study the rela-
tionship between sex and paediatric intensive care 
unit (PICU) mortality where sex was both the primary 
exposure, or used as an adjustment variable.
 ► We have ensured wide coverage of the literature by 
selecting a broad date range.
 ► Although we focus on the relationship between sex 
and PICU mortality as a primary aim, our review is 
not designed to estimate causal associations.
 ► Limiting articles to those published in the English 
language will introduce bias, but the proportion of 
excluded articles due to publication language will be 
assessed and reviewed for future inclusion if 20% or 
more are excluded.
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studies that have examined this issue, reaching similar 
conclusions,5–7 but there is no systematic review to collate 
and evaluate all the available evidence on this.
For this reason, we aim to conduct a systematic literature 
review to study the differences in mortality rates between 
males and females aged 0–17, who die in PICU. This liter-
ature review will address the questions of: whether there 
is a difference between the two sexes in PICU mortality, 
and if so, the magnitude and direction of this difference. 
This can be pertinent to clinical care in identifying a risk 
group (in this case male or female children) in which clin-
ical practice maybe be tailored to address specific needs 
and allocate resources. This review is also part of a wider 
project using linked PICU and Hospital Episode Statistics 
data which aims to study differences in sex mortality and 
long term outcomes in England.8
Aims and objectives
Using published data, our overall primary aim is to 
gather evidence on whether there is a mortality differ-
ence between males and females admitted to PICU. Our 
secondary aim is to quantify the rates of admission to 
PICU for males and females. Our specific objectives are 
to report on the evidence with regard to:
 ► The rates of admission to PICU for all children aged 
0–17 years by sex.
 ► The rates of mortality by sex and their difference 
(absolute or relative, as available) in children admitted 
to PICU aged 0–17 years.
 ► These rates overall and by any primary diagnostic 
groups.
Review question
Following the conclusions of the 11 year study,4 this review 
will focus on death while in PICU, rather than overall death. 
The review question is outlined in more detail in table 1.
METHODS
We report our protocol using the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses Protocols 
(PRISMA- P) guidelines9 (online supplemental appendix 
1- PRISMA- P checklist). Any amendments to the protocol 
will be made through PROSPERO. For this review, we will 
make use of the systematic review software DistillerSR 
(DistillerSR, Evidence Partners, Ottawa, Canada). For all 
processes from abstract and title screening to the final 
evidence synthesis, we will make use of the functionalities 
and built- in forms within DistillerSR.
If it is possible to combine the results of the included 
studies, we will also carry out a meta- analysis of the 
outcome of mortality in PICU.
Search strategy
The aim of the search is to identify any studies that have 
directly or indirectly addressed the association between 
sex and mortality in children admitted to intensive care.
The search strings were based on terms related to the 
population (children in intensive care), the exposure 
(sex) and the outcome (mortality).
The search terms were chosen to be sufficiently broad 
to capture all publications including those that focus on 
a particular subgroup of admissions to intensive care, for 
example admissions restricted to a particular primary 
diagnostic group only. Examples of the MeSH terms used 
were ‘mortality or death’, ‘critical care or intensive care’, 
‘sex or gender’. The terms were expanded where neces-
sary to capture a wide range of studies. The search was not 
restricted to any languages, however, the full- text selec-
tion will exclude non- English articles. This is to provide 
an idea of the proportion of excluded non- English titles 
and abstracts that are deemed suitable for full text review. 
If there is a high proportion of such titles and abstracts, 
then an amendment to the strategy may be necessary to 
include articles published in non- English languages.
We carried out the search using the databases MEDLINE 
(via Ovid 1946–February week 4 2020), Embase (via Ovid 
1980–2020 week 52) and Web of Science (1985–2020) as 
these cover relevant clinical publications. The search strategy 
was refined after we reviewed the relevance of preliminary 
searches. The search strategies and the steps taken to refine 
the search along with the numbers of records found are 
detailed in figure 1 and online supplemental appendix 2.
Given the large number of initial records found, we 




 ► Mortality in PICU.
Secondary outcomes
 ► Length of Stay in PICU.
 ► Hospital mortality.
 ► Length of stay in hospital.
 ► Factors associated with differences in mortality rates 
for sexes.
Table 1 The review question following the PECO model
Population Children aged 0–17 years of age, and admitted to a paediatric intensive care unit
Exposure Sex is the exposure of interest
Comparison Comparing male and female mortality rates
Outcome Death within a paediatric intensive care unit
PECO, Population, Exposure, Comparison, Outcomes.
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Figure 1 Data flow diagram. *These records are detailed in online supplemental table A1 in online supplemental appendix 2. 
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta- Analyses.
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We will include any observational study or reanalysis of 
randomised controlled trials reporting on the following:
 ► Children aged 0–17 years who have been admitted to 
a PICU/ICU.
 ► Reporting on mortality in PICU/ICU, either as a 
primary or secondary outcome.
 ► Reporting on sex differences (absolute or relative, 
as reported) in mortality, either as a main analysis 
or where sex is used as an adjustment variable for 
mortality.
Study exclusion criteria
 ► Studies meeting at least one of the exclusion criteria 
will be excluded.
 ► Studies exclusively addressing those admitted to 
neonatal units.
 ► Studies that only include premature or very low birth-
weight neonates.
 ► Studies that are only published in abstract form, or 
are review articles.
 ► Studies involving adult or mixed adult and paediatric 
populations. If the mixed adult and paediatric studies 
report separate results for the paediatric population, 
they will be considered.
 ► Studies that do not report PICU mortality as an 
outcome.
 ► Studies that do not report PICU mortality outcome by 
categories of sex.
 ► Studies not in English. However, the number of 
studies will be assessed after the title and abstract 
review stage. If more than 20% of the first stage full 
text reviews are not in English, a discussion between 
the reviewers will take place on whether the protocol 
needs to be updated to include these studies.
Study screening mode
Screening studies: applying inclusion and exclusion criteria
Before applying the study criteria, and to aid speeding the 
screening process, the lead author (OA) will remove irrele-
vant publication types such as conference abstracts, reviews 
and books. In the first instance, one reviewer will apply the 
inclusion and exclusion criteria to the title and abstract, to 
remove spurious citations. A sample of the reviewed titles 
and abstracts containing all the inclusions and a sample of 
the exclusions (twice the number of the inclusions) will be 
screened by the second reviewer. Discrepancies at the title 
and abstract review stage will be resolved by a third reviewer. 
The third reviewer will only screen the titles and abstracts 
with disagreements. We will review the full text of the articles 
selected from the title and abstract reviews in two stages. In 
the first stage, we will apply rapid exclusion of any articles that 
meet any of the exclusion criteria, see online supplemental 
appendix 3–stage 1 full- text screening tool. The first stage of 
full- text review will be applied by one reviewer and checked 
by a second. The remaining articles will go through a second 
stage full- text review and data extraction by one reviewer, 
then checked by a second reviewer.
Screening studies: quality assurance process
We will calculate a Kappa statistic for the agreement in 
inclusion/exclusions when applied to titles and abstracts, 
and to the first phase of full- text review level in order to 
measure agreement between the reviewers.
Critical appraisal of included studies
We will assess the reliability of included studies using the 
risk of bias in observational studies of exposures tool,11 12 
which includes criteria for judging studies to be of high, 
unclear and low risk of bias. We will assess the studies 
for external validity using the same tool. Two reviewers 
will independently assess the methodological quality for 
eligible studies based on the criteria set out in table 2. 
Any publication with a disagreement over the risk of bias 
between the two authors will be reviewed independently 
by the third reviewer.
Critical appraisal mode
Two viewers will apply the criteria of the critical appraisal 
independently and discrepancies will be resolved by a third 
reviewer.
Data extraction strategy
We will use the DistillerSR software for data extraction 
and make use of the built in data extraction templates. 
Table 2 The study eligibility criteria following the PECO model
PECO Inclusion criteria Exclusion criteria
Population Children 0 to <18 years admitted to PICU Studies with premature neonates or focusing on very low 
birthweight infants.
Studies with mixed adult and paediatric populations
Exposure Sex used as a primary exposure for mortality 
sex used as covariate for adjustment
Mortality not reported by sex.
Sex as primary exposure or covariate for adjustment only in 
non- mortality outcomes.
Comparison Comparing male to female mortality Comparisons between categories other than sex only.
Outcomes Primary: mortality in
PICU
Primary outcome not reported.
PECO, Population, Exposure, Comparison, Outcomes; PICU, paediatric intensive care unit.
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The proposed data extraction tool will be piloted by the 
three reviewers (OA, AF and LP) using two studies each 
before any amendments are made. Data extraction will 
be performed by the main reviewer, OA. Two reviewers 
(AF and LP) will share the task of second checking the 
extracted data.
We will tabulate the data items then generate a 
summary of studies’ table. Data items of interest will be 
the age range of children admitted to critical care, if sex 
was used as a main exposure variable or one for adjust-
ment, sample size of the study and the estimand used to 
compare mortality rates. The full data extraction sheet 
is available in online supplemental appendix 4- proposed 
data extraction tool and the risk of bias tool in online 
supplemental appendix 5- risk of bias Tool. Studies 
directly addressing the association will be eligible for data 
extraction. We will only report a summary of the estimates 
for studies where sex was used as an adjustment variable.
Data analysis and synthesis
We will carry out the analysis in Stata 16 or R software. 
We will carry out a narrative synthesis of the data, and 
depending on how mortality comparisons are calculated, 
the degree of similarities between the study designs, and 
the heterogeneity of the results, we may also summarise 
the estimates in a pooled effect. Although the outcome 
studied here is mortality, and therefore, quite clear to 
extract from the studies, the design and analysis of each 
study may vary considerably such that it would not be 
possible to combine the results in a meta- analysis.
We will consider a pooled effect if we have at least three 
studies with similar periods of follow- up and adjustment 
variables. We will consider analysis by subgroups if we 
have at least three studies with the same sub- population of 
primary diagnostic group, for example, studies conducted 
only on children with sepsis.
It may be possible to combine the crude estimate of 
studies with a similar length of stay. In which case we may 
combine the crude mortality estimates from individual 
studies in a meta- analysis to provide a pooled crude effect. 
If there are at least three studies, we will assess hetero-
geneity by calculating the Cochran’s Q statistic, and the 
I2 statistic to describe the percentage of variation across 
studies that is due to heterogeneity rather than chance.
We will extract the following data from each included 
study:
1. Publication date, country and setting (single centre or 
multi- centre) in which the study was conducted.
2. Study design and sample size.
3. Analysis of the entire PICU population or a subpopula-
tion by primary diagnostic group.
4. Participant characteristics such as age range.
5. Features of the study: mortality (primary or second-
ary); type of effect measure (OR, HR or risk ratio 
(RR)); follow- up period. Secondary outcomes will also 
be extracted.
6. If sex was used as a primary exposure variable or as an 
adjustment variable
7. Reporting of estimates: adjusted, unadjusted and any 
adjustment variables used. The rationale for the inclu-
sion of any adjustment variables.
8. Statistical model(s) used.
The effect size we report will depend on what the indi-
vidual studies report. Possible estimands can be OR, RR, 
risk difference or HR.
We will extract the measure of association reported in 
each study along with its SE or CIs, depending on the 
subpopulation, the age group, the length of stay and the 
set of adjustment variables used in each study. We will 
present quantitative results from the included studies in 
tables and/or charts, and discuss them narratively.
Sensitivity analyses
We will carry out the following sensitivity analyses:
 ► Assess the impact of excluding studies with a high risk 
of bias.
 ► Assess the impact of excluding studies that involve 
only subpopulations of PICU.
 ► Should we exclude non- English publications, we will 
assess the impact of their exclusion.
Dealing with missing data
When the necessary data are not available in the included 
study or its incorporated studies, we will attempt to 
contact the authors of the primary studies.
Ethics and dissemination
Ethical approval is not required for this review as it will 
synthesise data from existing studies. This manuscript 
is a part of a larger data linkage study, for which Ethical 
approval was granted by the London - City & East Research 
Ethics Committee, REC reference: 19/LO/1396, IRAS 
project ID: 214 031. Dissemination will be via peer- 
reviewed journals and via public and patient groups.
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